Universitätsklinikum Essen, Westdeutsches Tumorzentrum - Innere Klinik
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wiesweg, Marcel
PACE-LUNG, NCT05281406 / 2019-004757-88: Additional Chemotherapy for EGFRm Patients With the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib 1st-line Treatment

Recruiting
2
50
Europe
Osimertinib, Tagrisso, Pemetrexed, Cisplatin, Carboplatin
Goethe University
NSCLC Stage IIIB, NSCLC Stage IV
11/23
11/26
NCT04318938: Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

Active, not recruiting
2
118
Europe
Brigatinib, Study treatment, Tyrosine kinase inhibitor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Thoraxklinik-Heidelberg gGmbH, Takeda
NSCLC
01/26
01/26
PYNNACLE, NCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Recruiting
1/2
230
Europe, US, RoW
PC14586, rezatapopt, pembrolizumab, KEYTRUDA®, MK-3475, KEYNOTE-D79, MK-3475-D79
PMV Pharmaceuticals, Inc, Merck Sharp & Dohme LLC
Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor, Lung Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Breast Cancer, Other Cancer, Locally Advanced, Head and Neck Cancer
03/26
07/26
BREATH, NCT06374160: Exercise in Patients With Advanced Non-small Cell Lung Cancer

Not yet recruiting
N/A
104
Europe
Exercise intervention
University Hospital, Essen, German Cancer Aid
Advanced Lung Carcinoma, First Line Treatment, Second Line Treatment, NSCLC Stage IV, NSCLC Stage IIIB, Palliative Treatment, NSCLC Stage IIIC
04/26
08/26

Download Options